Cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C

被引:0
|
作者
Jacobs, RJ [1 ]
Koff, RS
机构
[1] Capitol Outcomes Res Inc, Alexandria, VA USA
[2] Univ Massachusetts, Sch Med, Boston, MA 02125 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:873 / 874
页数:2
相关论文
共 50 条
  • [31] Relative cost-effectiveness for the retreatment of chronic hepatitis C.
    Saab, S
    Han, SH
    Martin, P
    GASTROENTEROLOGY, 2000, 118 (04) : A1483 - A1483
  • [32] Cost-effectiveness of treatment for chronic hepatitis C infection - Reply
    Salomon, JA
    Goldie, SJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (15): : 1994 - 1994
  • [33] Cost-effectiveness of interferon treatment for chronic hepatitis C.
    Kareemi, M
    Peltekian, KM
    HEPATOLOGY, 1996, 24 (04) : 597 - 597
  • [34] The cost-effectiveness of boceprevir for hepatitis C
    Neoh, Chin Fen
    Kong, David C. M.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2014, 14 (03) : 319 - 334
  • [35] VIRAL HEPATITIS Cost-effectiveness of direct-acting antivirals for chronic hepatitis C
    Sroczynski, Gaby
    Siebert, Uwe
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (10) : 572 - 574
  • [36] Cost-effectiveness of hepatitis A/B vaccination in the private sector
    Jacobs, RJ
    Meyerhoff, AS
    SEXUALLY TRANSMITTED DISEASES, 2005, 32 (08) : 465 - 465
  • [37] Cost-effectiveness of hepatitis A vaccination in children, adolescents, and adults
    Rosenthal, P
    HEPATOLOGY, 2003, 37 (01) : 44 - 51
  • [38] Cost-Effectiveness of Adult Universal Hepatitis B Vaccination
    Oster, Gerry
    Bornheimer, Rebecca
    Ottino, Kevin
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (12): : 2239 - 2241
  • [39] Cost-effectiveness of hepatitis E virus vaccination strategy
    Kato, Hideaki
    HEPATOLOGY RESEARCH, 2024, 54 (02) : 122 - 124
  • [40] Cost-effectiveness of universal childhood hepatitis A vaccination in Chile
    Valenzuela, MT
    Jacobs, RJ
    Arteaga, O
    Navarrete, MS
    Meyerhoff, AS
    Innis, BL
    VACCINE, 2005, 23 (32) : 4110 - 4119